Study shows human monoclonal antibodies can effectively neutralize SARS-CoV-2

Study shows human monoclonal antibodies can effectively neutralize SARS-CoV-2

Study shows human monoclonal antibodies can effectively neutralize SARS-CoV-2

US researchers have published a proof of concept on the efficacy of human monoclonal antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in laboratory conditions, as well as their pioneering use in a mouse model. The study is available on the preprint server bioRxiv*.